drugset / Trial / NCT00805870

The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers

NCT00805870 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effects of fish oil supplementation (Lovaza, GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.

Timeline

Start
2009-03
Primary completion
2009-12
Completion
2010-02

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Fish Oil vs Control; p >0.05; Mean Difference (Net) 8.271 (95% CI -63.521 to 46.978); ANOVA NCT00805870 ↗

registry analysis (superiority or other test); Fish Oil vs Control; p >0.05; Mean Difference (Net) -1.845 (95% CI -4.823 to 1.132); ANOVA NCT00805870 ↗

registry analysis (superiority or other test); Fish Oil vs Control; p >0.05; Mean Difference (Net) -57.015 (95% CI -156.373 to 42.344); ANOVA NCT00805870 ↗

registry analysis (superiority or other test); Fish Oil vs Control; p >0.05; Mean Difference (Net) 0.022 (95% CI -0.374 to 0.417); ANOVA NCT00805870 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 3 g —

Indications